Skip to main content
logo
Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0970
-0.0014 (-1.42%)
Aug 13, 2026, 5:20 PM CET

Prostatype Genomics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.60.61.983.790.682.52
Revenue Growth
-16.62%-69.89%-47.64%454.47%-72.92%101.64%
Gross Profit
0.180.61.983.790.682.52
Operating Income
-39.36-38.94-40.85-39.25-28.69-15.55
Net Income
-44.5-44.5-41.05-41.44-29.09-15.63
Earnings Per Share
-1.32-1.32-14.93-512.68-1597.90-1120.57
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
9.079.079.422.6811.4920.33
Total Debt
5.35.30.0711.670.871.27
Net Cash (Debt)
3.773.779.35-8.9910.6219.06
Net Cash Growth
-70.86%-59.71%---44.28%32.42%
Net Cash Per Share
0.110.110.28-111.17583.531366.72

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-23.8-23.8-44.71-29.14-27.69-16.08
Capital Expenditures
-0.26-0.26-0.29-0.08--
Free Cash Flow
-24.06-24.06-44.99-29.21-27.69-16.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
29.65%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-6592.63%-6522.28%-2060.21%-1036.36%-4200.44%-616.55%
Pretax Margin
-7454.44%-7454.44%-2070.15%-1094.14%-4258.71%-619.78%
Profit Margin
-7454.44%-7454.44%-2070.15%-1094.14%-4258.71%-619.78%
FCF Margin
-4029.98%-4029.98%-2268.99%-771.40%-4054.61%-637.56%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
9.8129.7437.531.417.155.39